EMA — authorised 9 February 2012
- Application: EMEA/H/C/002140
- Marketing authorisation holder: Galpharm Healthcare Ltd.
- Local brand name: Sumatriptan Galpharm
- Status: rejected
🇪🇺 Sumatriptan 5% in European Union
EMA authorised Sumatriptan 5% on 9 February 2012
Marketing authorisation
Frequently asked questions
Is Sumatriptan 5% approved in European Union?
Yes. EMA authorised it on 9 February 2012.
Who is the marketing authorisation holder for Sumatriptan 5% in European Union?
Galpharm Healthcare Ltd. holds the EU marketing authorisation.